Furthermore, in patients in whom P-HGP dominance reached and exceeded 60% of the tumor-peritoneal interface, the median OS was better than in those with a P-HGP <60%: 131 versus 41 months, respectively (p = 0.044; Fig. 4). Here, SLC25A16 is linked to neoplasm.